Systemic Embolism clinical trials at University of California Health
1 in progress, 0 open to eligible people
Showing trials for
Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination
Sorry, not currently recruiting here
The purpose of this study is to compare the safety and effectiveness of Laminar Left Atrial Appendage Closure (LAAC) device as compared to the commercially available LAAC devices in participants with non-valvular atrial fibrillation (NVAF) to reduce the risk of stroke (blocked blood vessel or bleeding in brain) and systemic embolism (blockage in a blood vessel harming vital organs).
at UC Davis
Last updated: